Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00344175
Status:
COMPLETED
Last Update Posted:
2010-02-02
First Post:
2006-06-22
Brief Title:
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
Sponsor:
Kowa Research Europe
Organization:
Kowa Research Europe
Study Overview
Official Title:
Double-blind follow-on Study of Pitavastatin 4mg Versus Simvastatin 40mg and 80mg With a Single-blind Extension of Treatment in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304
Detailed Description:
This is a sixteen-week double-blind active controlled follow-on and 28 week single blind extension study for patients who participated in NK-104-304
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None